A study shows that transplantation of one’s blood-forming stem cells after high-dose immunosuppressive may induce remission of multiple sclerosis. Multiple sclerosis (MS) is a condition in which an individual’s immune system attacks his or her central nervous system. The study was conducted over a period of about five years. It was published in the American Academy of Neurology journal.
From the research, 69 percent of the participants (patients) who underwent high-dose immunosuppressive therapy and autologous hematopoietic cell transplant treatment (HDIT/HCT) did not experience progression of disability, new brain lesions, and relapse of MS symptoms. In other studies, it has been found that MS drugs available in the market have limited success rate in treating the disease. The National Institute of Allergy and Infectious Diseases (NIAID) sponsored the study. The first results of the study were posted in December 2014.
According to Anthony S. Fauci, M.D., long-term treatment of MS even with the best medications in the market is less efficient than one-time treatment with HDIT/HCT. He also pointed out that MS varies from one person to another. Fauci added that the results of these studies support the need to conduct a large and randomized trial. He believes that this process will help produce reliable data that could be used to compare the success of HDIT/HCT treatments to standard MS care. MS symptoms include weakness, fatigue, motor and speech difficulties, and chronic pain. The most common type of MS is relapsing-remitting MS. This information was originally reported on the National Institutes of Health (NIH) as highlighted in this link https://www.nih.gov/news-events/news-releases/stem-cell-transplants-may-induce-long-term-remission-multiple-sclerosis
About Shiva Gopal Vasishta
Dr. Shiva Gopal Vasishta is a new Jersey-based neurologist. He works at the Kennedy University Hospital. Here, Vasishta is part of a team of 34 doctors that specializes in Neurology. The doctor has broad experience in treating multiple sclerosis, sleep disorder, stroke, dementia, and headaches. Dr. Shiva Gopal Vasishta pursued his medical degree from the Government Medical College.
He successfully completed his residency in Neurology at Tufts Medical Center and Boston University Medical Center. Shiva is certified by the American Board of Psychiatry and Neurology and holds an NJ State Medical License. Dr. Shiva Gopal Vasishta practices psychiatry at the Eastern Neurodiagnostic Associates. Notably, Dr. Shiva Gopal Vasishta has been accepting different insurance plans, including Horizon Blue Cross Blue Shield, Medicare and Aetna.